Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors [Phase 2]
Phase 2 trial exploring high-dose chemotherapy with amifostine and autologous stem cell transplantation for high-risk relapsed pediatric sol…
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer [Phase 1]
Phase I study of MLN0128 and MLN8237 in patients with advanced solid tumors and metastatic triple-negative breast cancer completed; results …
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma [Phase 1, Phase 2]
Phase I/II trial evaluating epacadostat with intralesional SD101 and radiotherapy in lymphoma and advanced solid tumors has completed with r…
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) [Phase 1]
Phase 1 trial update of avelumab in metastatic or locally advanced solid tumors (JAVELIN Solid Tumor) with completed status and results post…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Study of INCB053914 in Subjects With Advanced Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial of INCB053914 in subjects with advanced solid tumors has been terminated with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial assessing safety, pharmacokinetics, and antitumor activity of BGB-A317 in combination with BGB-290 in advanced solid tumors; r…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation [Phase 1, Phase 2]
Phase 1/2 trial of LY3499446 in advanced solid tumors with KRAS G12C has been terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for durvalumab (MEDI4736) in combination with AZD9150 or AZD5069 in patients with advanced…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial update for lurbinectedin (PM01183) in selected advanced solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating vorinostat in combination with etoposide in pediatric patients under 21 with refractory solid tumors, co…
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update evaluating safety, dose tolerance, pharmacokinetics, and pharmacodynamics of CPX-POM in patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating niraparib as a single agent in participants with advanced solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations [Phase 1, Phase 2]
Phase 1/2 study of derazantinib (ARQ 087) in adults with advanced solid tumors carrying FGFR genetic alterations has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas [Phase 1]
Phase 1 trial update for Sym023 (anti-TIM-3) in patients with advanced solid tumors, metastatic cancer, or lymphomas; results posted after c…
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma [Phase 1, Phase 2]
Phase 1/2a study of BAL101553 given as 48-hour infusions in adults with advanced solid tumors or recurrent glioblastoma has completed testin…
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of X-396 (an oral ALK inhibitor) in ALK-positive non-small cell lung cancer and other advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study [Phase 1]
Phase 1 study update for MEN1309 intravenous infusion in CD205-positive metastatic solid tumors and relapsed/refractory non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Pamiparib in Participants With Advanced Cancer [Phase 1]
Phase 1 study evaluating absorption, metabolism, and excretion of radiolabeled pamiparib in participants with advanced cancer completed; res…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update for TY101 evaluating safety and efficacy in locally advanced/metastatic solid tumors and relapsed …
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y) [Phase 2]
A Phase 2 MATCH subprotocol evaluating AZD5363 (capivasertib) for cancers with AKT genetic alterations; the study is marked as active but no…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma [Phase 1]
Phase I study of Zalypsis (PM00104) in advanced malignant solid tumors or lymphoma; the trial status is terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: AZD1775 for Advanced Solid Tumors [Phase 1]
Phase 1 trial update for AZD1775 in advanced solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]
Phase 1/2 trial of USL311 +/- lomustine in advanced solid tumors and relapsed/recurrent glioblastoma multiforme (GBM) was terminated with re…
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) [Phase 1, Phase 2]
Phase I/II trial evaluating CBP501 in combination with pemetrexed and cisplatin for malignant pleural mesothelioma; study completed with pos…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Microtransplantation for Advanced and Relapsed Solid Tumors [Phase 1, Phase 2]
A clinical trial update on microtransplantation for advanced and relapsed solid tumors across Phase 1 and Phase 2.